Inventor · disambiguated record
Paul Alan Glossop
Also filed as: GLOSSOP PAUL · GLOSSOP PAUL A · GLOSSOP PAUL ALAN
25 granted patents·12 pending applications·67 citations·filing 2003–2024
94Inventor score
Top patents by PatentIndex Score
37 records- 0186US6844362B2Indole derivatives useful for the treatment of diseasesPFIZER·Filed 2003·Granted Jan 18, 2005·14 cites·11 claims
- 0285US7244766B2Sulfonamide derivatives for the treatment of diseasesPFIZER·Filed 2005·Granted Jul 17, 2007·7 cites·22 claims
- 0381US7528170B2Sulfonamide derivatives for the treatment of diseasesPFIZER·Filed 2007·Granted May 5, 2009·4 cites·2 claims
- 0480US8822439B2Glucocorticoid receptor agonistsGLOSSOP PAUL ALAN·Filed 2008·Granted Sep 2, 2014·4 cites·5 claims
- 0580US7767715B2Sulfonamide derivatives for the treatment of diseasesPFIZER·Filed 2009·Granted Aug 3, 2010·3 cites·3 claims
- 0680US7241810B2Formamide derivatives for the treatment of diseasesPFIZER·Filed 2005·Granted Jul 10, 2007·4 cites·15 claims
- 0780US7138527B2Indole derivatives useful for the treatment of diseasesPFIZER·Filed 2004·Granted Nov 21, 2006·8 cites·4 claims
- 0879US7772223B2Carboxamide derivatives as muscarinic receptor antagonistsPFIZER·Filed 2006·Granted Aug 10, 2010·3 cites·18 claims
- 0975US7183294B2Indole derivatives useful for the treatment of diseasesPFIZER·Filed 2004·Granted Feb 27, 2007·9 cites·45 claims
- 1073US9533989B2Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitorsZIARCO PHARMA LTD·Filed 2013·Granted Jan 3, 2017·2 cites·8 claims
- 1172US10961261B2Oxaborole analogs and uses thereofANACOR PHARMACEUTICALS INC·Filed 2018·Granted Mar 30, 2021·1 cites·20 claims
- 1272US7482487B2Phenylaminoethanol derivatives as β2 receptor agonistsPFIZER·Filed 2005·Granted Jan 27, 2009·2 cites·12 claims
- 1371US8263583B2Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamideGLOSSOP PAUL ALAN·Filed 2008·Granted Sep 11, 2012·1 cites·8 claims
- 1468US11866436B2Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereofCAMBRIDGE ENTPR LTD·Filed 2023·Granted Jan 9, 2024·0 cites·2 claims
- 1568US11691992B2Oxaborole analogs and uses thereofANACOR PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·20 claims
- 1668US2024409530A1Disubstituted Pyrimidine Compounds for Ketohexokinase InhibitionCENTENNIAL THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1766US7268147B2Compounds useful for the treatment of diseasesPFIZER·Filed 2004·Granted Sep 11, 2007·3 cites·18 claims
- 1865US8268881B2Carboxamide derivatives as muscarinic receptor antagonistsGLOSSOP PAUL ALAN·Filed 2009·Granted Sep 18, 2012·0 cites·15 claims
- 1964US7141586B2Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2004·Granted Nov 28, 2006·2 cites·13 claims
- 2061US7547731B2Formamide derivatives for the treatment of diseasesPFIZER·Filed 2007·Granted Jun 16, 2009·0 cites·6 claims
- 2158US2025345446A1Bifunctional molecules that selectively induce degradation of extracellular targets in lysosomesDRAUPNIR BIO APS·Filed 2023·Application pending·0 cites
- 2256US2024287060A1Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereofCAMBRIDGE ENTPR LTD·Filed 2022·Application pending·0 cites
- 2354US2014336160A1Novel glucocorticold receptor agonistsPFIZER·Filed 2014·Application pending·0 cites
- 2453US8013019B2Sulfonamide derivatives for the treatment of diseasesPFIZER·Filed 2010·Granted Sep 6, 2011·0 cites·11 claims
- 2550US2010016366A1Novel Compounds Active as Muscarinic Receptor AntagonistsGLOSSOP PAUL ALAN·Filed 2009·Application pending·0 cites
- 2649US8486992B2Carboxamide derivatives as muscarinic receptor antagonistsGLOSSOP PAUL ALAN·Filed 2010·Granted Jul 16, 2013·0 cites·4 claims
- 2748US2011306597A1Nicotinamide DerivativesCRAWFORTH JAMES MICHAEL·Filed 2009·Application pending·0 cites
- 2848US2009076152A1Novel Compounds Active as Muscarinic Receptor AntagonistsGLOSSOP PAUL ALAN·Filed 2008·Application pending·0 cites
- 2947US10065964B2Pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitorsZIARCO PHARMA LTD·Filed 2016·Granted Sep 4, 2018·0 cites·19 claims
- 3046US2010160279A1Azetidine Derivatives as Muscarinic Receptor AntagonistsPFIZER·Filed 2007·Application pending·0 cites
- 3144US2005215542A1Compounds for the treatment of diseasesPFIZER·Filed 2005·Application pending·0 cites
- 3243US11400081B2CompoundsUNIV SHEFFIELD·Filed 2018·Granted Aug 2, 2022·0 cites·21 claims
- 3343US7538141B2Compounds for the treatment of diseasesBROWN ALAN DANIEL·Filed 2005·Granted May 26, 2009·0 cites·12 claims
- 3441US2022023281A1Heterocyclic spiro-compounds as am2 receptor inhibitorsUNIV SHEFFIELD·Filed 2019·Application pending·0 cites
- 3541US2023036854A1Heterocyclic spiro-compounds as am2 receptor inhibitorsUNIV SHEFFIELD·Filed 2019·Application pending·0 cites
- 3640US7629358B2Compounds useful for the treatment of diseasesPFIZER·Filed 2005·Granted Dec 8, 2009·0 cites·11 claims
- 3735US2010303758A1Novel Glucocorticoid Receptor AgonistsGLOSSOP PAUL ALAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Alan Glossop files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →